STAT+: Pharmalittle: We’re reading about pharma lobbying, a disappointing Novo clinical trial, and much more
Pharmaceutical companies are boosting their spending on lobbying firms with connections to the White House
Pharmaceutical companies are boosting their spending on lobbying firms with connections to the White House
Hyderabad: A case of alleged medical negligence has been registered against a paediatrician following the death of a six-month-old infant who was reportedly administered an expired injection at a private…
New Delhi: The Indian Council of Medical Research (ICMR), under the Department of Health Research (DHR), Ministry of Health and Family Welfare, organized SANVAD 2026 (Scholars' Assembly for Next-gen Ventures…
New Delhi: The National Medical Commission (NMC) has proposed making it mandatory for medical colleges to maintain a dedicated corpus fund, as part of draft amendments to the Establishment of…
Surguja: In a shocking incident at Kunni Village Community Health Centre (CHC) in Chhattisgarh's Surguja, a newborn died during delivery after a sweeper reportedly tried to assist the birth in…
Novo Nordisk's next-generation obesity drug CagriSema underperformed versus Eli Lilly's Zepbound in a head-to-head study.
Ujjain: In a tragic incident, a second-year MBBS student died in a road accident in Ujjain. The incident occurred Saturday morning when he was hit by a speeding truck near…
Business is booming for Trump-connected lobbying firms as pharma giants see new opportunity to influence the FDA.
Lobbyists told STAT they believe the odds of approval go up if a decision can be spun as a win for the Trump administration.
New Delhi: The All India Institute of Medical Sciences (AIIMS), New Delhi, has released an addendum announcing revisions in seat availability for the Open Round of Institute of National Importance…